Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (38)

2024

  1. Author Correction: Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia (Scientific Reports, (2023), 13, 1, (17724), 10.1038/s41598-023-45007-4)

    Scientific Reports

  2. Comprehensive study of mechanical power in controlled mechanical ventilation: Prevalence of elevated mechanical power and component analysis

    Medicina Intensiva, Vol. 48, Núm. 3, pp. 155-164

  3. Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults

    European Journal of Internal Medicine, Vol. 119, pp. 93-98

2023

  1. Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome

    Scientific Reports, Vol. 13, Núm. 1

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  3. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  2. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia

    ERJ Open Research, Vol. 7, Núm. 1

  3. High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

    Journal of Infection

2020

  1. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 3, pp. 267-276

  2. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: Study protocol for a randomized controlled superiority trial

    Trials, Vol. 21, Núm. 1

  3. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388

  4. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria

    Anaesthesia Critical Care and Pain Medicine, Vol. 39, Núm. 5, pp. 553-561

2019

  1. Factors associated with ventilator-associated events: an international multicenter prospective cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 9, pp. 1693-1699

  2. Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis

    Annals of Intensive Care, Vol. 9, Núm. 1

2018

  1. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study

    Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2017

  1. Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130